English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biogen, Inc.
Press release submission
| Jul 2, 2019
BIOGEN, INC.: Announces New Data Further Establishing SPINRAZA® (nusinersen) as a Foundation of Care in Spinal Muscular Atrophy for a Broad Range of Patients
Trending
Patient Daily
| Aug 4, 2025
Independent review finds MAHA Report scientifically unsound
Patient Daily
| Aug 1, 2025
Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
Patient Daily
| Aug 4, 2025
Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+
Pharmaceuticals
Patient Daily
| Jul 30, 2025
American Lung Association criticizes EPA delay on methane pollution rules